Investor outlet: ‘AI can do things a radiologist can’t even come close to doing’

Seven months ago, the tech-investor website Nanalyze presented a list of nine AI startups intent on disrupting radiology. Its list has now topped 40. And its editors are more bullish than ever on the prospect of machines pushing radiologists to “move on to more value-added activities.”

“It’s not just that AI can provide a substitute for a radiologist, it’s that AI can do things that a radiologist can’t even come close to doing,” Nanalyze states in a piece published Aug. 19. “[I]t’s not just the image that AI can evaluate in isolation, but rather AI algorithms can take into account a patient’s entire electronic health record. Your prior medical history can provide a wealth of information that the algorithm could begin to make associations with over time. Imagine a radiologist trying to digest all that data before sitting down to look at 100,000 images.”

The thrust of the article is on Watson-powered IBM as a strong investment bet (and, in a sidebar, the editors misidentify radiologic technologists as image interpreters), but the piece is worth a read for its investor’s-eye perspective on AI developers’ keen interest in radiology.

Click to read:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.